|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2450 CAD | 0.00% |
|
+4.26% | -3.92% |
| 11-20 | Vext Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
| 11-20 | Vext Science, Inc., Q3 2025 Earnings Call, Nov 20, 2025 |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||
Cultivation, Manufacturing, Distribution and Sale of Cannabis | - | - | - | 34.81M | 36M | |||
Total Assets | - | - | - | 150M | 137M | |||
Interest Expense | - | - | - | -3.81M | -3.55M | |||
Income Tax Expense | - | - | - | -1.04M | 1.31M | |||
CAPEX | - | - | - | -2.74M | -1.47M | |||
EBT | - | - | - | 3.36M | -21.12M | |||
Gross Profit | - | - | - | 12.04M | 8.98M | |||
D&A | - | - | - | 9.59M | 15.18M | |||
Net Income | - | - | - | 4.4M | -22.44M | |||
Services and Products Relating to Cannabis for Medical Purposes | 25.19M | - | - | - | - | |||
Income Tax Expense | 514K | - | - | - | - | |||
Total Assets | 55.45M | - | - | - | - | |||
Net Income | 2.09M | - | - | - | - | |||
Oil and Gas Refining and Marketing | ||||||||
Liquid Gas Sales | - | - | - | - | - | |||
Total Assets | - | - | - | - | - | |||
Net Income | 36.38K | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
United States | 25.19M | 37.24M | 35.41M | 34.81M | 36M | |||
Total Assets | 55.45M | 83.7M | 121M | 150M | 137M | |||
Interest Expense | -27.62K | -35.49K | -2.04M | -3.81M | -3.55M | |||
Income Tax Expense | 514K | 1.83M | -4.22M | -1.04M | 1.31M | |||
D&A | 2.14M | 3.29M | 6.43M | 9.59M | 15.18M | |||
CAPEX | -4.06M | -18.78M | -8.86M | -2.74M | -1.47M | |||
Gross Profit | 9.9M | 16.43M | 23.1M | 12.04M | 8.98M | |||
Net Income | 2.13M | 4.99M | 10.92M | 4.4M | -22.44M | |||
EBT | 2.64M | 6.82M | 6.7M | 3.36M | -21.12M |
- Stock Market
- Equities
- VEXT Stock
- Financials Vext Science, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition